PURPOSE: To evaluate the type and number of diagnostic interventions needed to confirm the presence of vitreoretinal lymphoma. METHOD: Chart review of interventions performed for diagnosis of vitreoretinal lymphoma. RESULTS: Of the 27 cases, diagnosis was made by pars plana vitrectomy in 13 (48.1%), vitreous tap in 2 (7.4%), anterior chamber tap in 1 (3.7%), chorioretinal biopsy in 2 (7.4%), brain biopsy in 5 (18.5%), and cerebrospinal fluid cytology via lumbar puncture in 4 (14.8%). Ten (37%) had definitive results on the first procedure, and 17 (63%) had at least one false negative. Vitrectomy was the most common procedure performed. Patients required a mean of 2.1 procedures. Average time from onset of symptoms to confirmed histopathologic diagnosis was 13.9 months. CONCLUSION: Vitreoretinal lymphoma is difficult to recognize and requires a high degree of clinical suspicion. It often takes more than one invasive procedure to make the diagnosis.
PURPOSE: To evaluate the type and number of diagnostic interventions needed to confirm the presence of vitreoretinal lymphoma. METHOD: Chart review of interventions performed for diagnosis of vitreoretinal lymphoma. RESULTS: Of the 27 cases, diagnosis was made by pars plana vitrectomy in 13 (48.1%), vitreous tap in 2 (7.4%), anterior chamber tap in 1 (3.7%), chorioretinal biopsy in 2 (7.4%), brain biopsy in 5 (18.5%), and cerebrospinal fluid cytology via lumbar puncture in 4 (14.8%). Ten (37%) had definitive results on the first procedure, and 17 (63%) had at least one false negative. Vitrectomy was the most common procedure performed. Patients required a mean of 2.1 procedures. Average time from onset of symptoms to confirmed histopathologic diagnosis was 13.9 months. CONCLUSION:Vitreoretinal lymphoma is difficult to recognize and requires a high degree of clinical suspicion. It often takes more than one invasive procedure to make the diagnosis.
Authors: Jason M L Miller; Emily Chang; Cagri G Besirli; Mark W Johnson; Hakan Demirci Journal: Graefes Arch Clin Exp Ophthalmol Date: 2021-01-04 Impact factor: 3.117
Authors: David E Kuo; Maggie M Wei; Jared E Knickelbein; Karen R Armbrust; Ian Y L Yeung; Aaron Y Lee; Chi-Chao Chan; H Nida Sen Journal: Ophthalmology Date: 2020-02-05 Impact factor: 12.079
Authors: Rodolfo Mastropasqua; Emma Di Carlo; Carlo Sorrentino; Cesare Mariotti; Lyndon da Cruz Journal: J Clin Med Date: 2019-10-19 Impact factor: 4.241
Authors: Justine R Smith; Alexandra L Farrall; Janet L Davis; Joke H de Boer; Anthony J Hall; Manabu Mochizuki; H Nida Sen; Hiroshi Takase; Ninette H Ten Dam-van Loon; Valérie Touitou; Daniel V Vasconcelos-Santos; David J Wilson; Steven Yeh; Mark H B Radford Journal: BMJ Open Date: 2022-07-28 Impact factor: 3.006